Group 1 - The company announced the resignation of Ms. Huang Peiqiao as a co-secretary, effective from December 31, 2025 [1] - Ms. Liu Ling has been confirmed by the Stock Exchange to meet the qualifications to serve as the company secretary, thus no further exemption is required [1] - Following Ms. Huang's resignation, Ms. Liu will continue as the sole company secretary starting from December 31, 2025 [1] Group 2 - Ms. Huang has also resigned as the authorized representative according to the listing rules, effective from the same date [1] - The board has appointed Ms. Liu as the authorized representative to replace Ms. Huang, effective from December 31, 2025 [1] - Executive Director Mr. Zhou Yan will continue to serve as another authorized representative [1]
艾美疫苗(06660)：黄沛翘辞任联席公司秘书